Cherry Juice

drug
On this page

Also known as Prunus cerasus (bitter cherry) juicePrunus cerasus fruit juiceSour cherry fruit juiceSour cherry juiceTart cherry juice

Summary

Cherry Juice (CHEMBL2108181) is a phase-3 clinical-stage unknown.

At a glance

  • Status: Max clinical phase 3 (not approved)
  • Modality: Unknown
  • Clinical trials: 15

Identifiers

Drug identity and classification

FieldValue
ChEMBL IDCHEMBL2108181
NameCherry Juice
TypeUnknown
Max phase3

Also known as: Cherry juice, Prunus cerasus (bitter cherry) juice, Prunus cerasus fruit juice, Sour cherry fruit juice, Sour cherry juice, Tart cherry juice, CHERRY JUICE

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 15.

Phase distribution

PhaseTrials
Not specified13
PHASE41
PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00733395PHASE4COMPLETEDHood to Coast Injury Study
NCT06268665PHASE2RECRUITINGTart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
NCT00847743Not specifiedCOMPLETEDStudy on Whether Tart Cherry Juice Can Reduce Oxidative Stress and Inflammation
NCT01528202Not specifiedCOMPLETEDTart Cherries and Melatonin Content
NCT02922920Not specifiedCOMPLETEDEffects of Tart Cherry Juice on the Body
NCT03522779Not specifiedCOMPLETEDAntioxidant Responses to Exercise and Cherry Consumption
NCT03621215Not specifiedTERMINATEDThe Effect of Tart Cherry Juice on Risk of Gout Attacks
NCT03636529Not specifiedCOMPLETEDTart Cherry Juice and Markers of Inflammation, CVD, and Diabetes
NCT03638362Not specifiedCOMPLETEDTart Cherry Juice and Chronic Disease Risk
NCT03743519Not specifiedCOMPLETEDThe Efficacy of a Tart Cherry Drink for the Treatment of Patellofemoral Pain in Recreational Athletes.
NCT03948061Not specifiedCOMPLETEDCardiometabolic Effects of Sweet Cherry Juice
NCT04840160Not specifiedCOMPLETEDInfluence of Tart Cherry Juice Intervention on Vascular Function
NCT04960527Not specifiedCOMPLETEDAcute Effects of Tart Cherry on Uric Acid and Biomarkers of CVD Risk in Healthy Individuals
NCT05281198Not specifiedTERMINATEDEffects of Exercise & Tart Cherry Ingestion on Heat Acclimation and Gut Microbiome
NCT06786494Not specifiedCOMPLETEDTart Cherry Juice for Sleep in Older Adults With Insomnia: A Pilot Study of Feasibility and Comprehensive Mechanisms

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.